-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JafUtXCU2Ytop2GbVn1fhU1wgcssOs6NuKUw443swWihXq2BhDwgRqeGGElme4fc rI/r0g0u8DcU+E8swYVyjg== 0001011240-97-000036.txt : 19970404 0001011240-97-000036.hdr.sgml : 19970404 ACCESSION NUMBER: 0001011240-97-000036 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19970320 ITEM INFORMATION: FILED AS OF DATE: 19970403 SROS: AMEX FILER: COMPANY DATA: COMPANY CONFORMED NAME: KV PHARMACEUTICAL CO /DE/ CENTRAL INDEX KEY: 0000057055 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 430618919 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-09601 FILM NUMBER: 97574230 BUSINESS ADDRESS: STREET 1: 2503 S HANLEY RD CITY: ST LOUIS STATE: MO ZIP: 63144 BUSINESS PHONE: 3146456600 MAIL ADDRESS: STREET 1: 2503 S HANLEY RD CITY: ST LOUIS STATE: MO ZIP: 63144 8-K 1 FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 20, 1997 Date of report (Date of earliest event reported) K-V PHARMACEUTICAL COMPANY (Exact name of Registrant as specified in its charter) Delaware 1-9601 43-0618919 (State or other (Commission (IRS Employer jurisdiction of File Number) Identification No.) incorporation) 2503 South Hanley Road, St. Louis, Missouri 63144 (Address of principal executive offices) (Zip Code) (314) 645-6600 (Registrant's telephone number, including area code) Item 9. Sales of Equity Securities Pursuant to Regulation S On March 20, 1997, K-V Pharmaceutical Company (the "Company") completed its sale of 200,000 previously unissued shares of the Company's Class A Common Stock, par value $0.01 per share, to Roche International, Ltd. of Hamilton, Bermuda for cash consideration in the amount of $3,500,000 in a transaction exempt from the registration requirements of the Securities Act of 1933 by reason of Regulation S promulgated thereunder. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereto duly authorized. Date: April 2, 1997 K-V PHARMACEUTICAL COMPANY By: /s/ Gerald R. Mitchell --------------------------- Gerald R. Mitchell Vice President - Finance 3 -----END PRIVACY-ENHANCED MESSAGE-----